112 related articles for article (PubMed ID: 37270166)
1. Prognostic Role of Circulating LTBP-2 in Patients With Dilated Cardiomyopathy: A Novel Biomarker Reflecting Extracellular Matrix LTBP-2 Accumulation.
Nishiura K; Yokokawa T; Misaka T; Ichimura S; Tomita Y; Miura S; Shimizu T; Sato T; Kaneshiro T; Oikawa M; Kobayashi A; Yoshihisa A; Takeishi Y
Can J Cardiol; 2023 Oct; 39(10):1436-1445. PubMed ID: 37270166
[TBL] [Abstract][Full Text] [Related]
2. Relationships between circulating galectin-3, extracellular matrix fibrosis and outcomes in dilated cardiomyopathy.
Rubiś P; Holcman K; Dziewięcka E; Wiśniowska-Śmiałek S; Karabinowska A; Szymonowicz M; Khachatryan L; Wypasek E; Garlitski A; Gackowski A; Podolec P
Adv Clin Exp Med; 2021 Mar; 30(3):245-253. PubMed ID: 33754503
[TBL] [Abstract][Full Text] [Related]
3. Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy.
Rubiś P; Wiśniowska-Śmialek S; Wypasek E; Biernacka-Fijalkowska B; Rudnicka-Sosin L; Dziewiecka E; Faltyn P; Khachatryan L; Karabinowska A; Kozanecki A; Tomkiewicz-Pająk L; Podolec P
Inflamm Res; 2016 Dec; 65(12):941-949. PubMed ID: 27516211
[TBL] [Abstract][Full Text] [Related]
4. Myocardial T-Lymphocytes as a Prognostic Risk-Stratifying Marker of Dilated Cardiomyopathy - Results of the Multicenter Registry to Investigate Inflammatory Cell Infiltration in Dilated Cardiomyopathy in Tissues of Endomyocardial Biopsy (INDICATE Study).
Ohta-Ogo K; Sugano Y; Ogata S; Nakayama T; Komori T; Eguchi K; Dohi K; Yokokawa T; Kanamori H; Nishimura S; Nakamura K; Ikeda Y; Nishimura K; Takemura G; Anzai T; Hiroe M; Hatakeyama K; Ishibashi-Ueda H; Imanaka-Yoshida K
Circ J; 2022 Jun; 86(7):1092-1101. PubMed ID: 35264513
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of fibrosis-related markers in dilated cardiomyopathy: A link between osteopontin and cardiovascular events.
Rubiś P; Wiśniowska-Śmiałek S; Dziewięcka E; Rudnicka-Sosin L; Kozanecki A; Podolec P
Adv Med Sci; 2018 Mar; 63(1):160-166. PubMed ID: 29120858
[TBL] [Abstract][Full Text] [Related]
6. Significance of myocardial tenascin-C expression in left ventricular remodelling and long-term outcome in patients with dilated cardiomyopathy.
Yokokawa T; Sugano Y; Nakayama T; Nagai T; Matsuyama TA; Ohta-Ogo K; Ikeda Y; Ishibashi-Ueda H; Nakatani T; Yasuda S; Takeishi Y; Ogawa H; Anzai T
Eur J Heart Fail; 2016 Apr; 18(4):375-85. PubMed ID: 26763891
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and prognostic relevance of myocardial inflammation and cardiotropic viruses in non-ischemic dilated cardiomyopathy.
Kažukauskienė I; Baltrūnienė V; Jakubauskas A; Žurauskas E; Maneikienė VV; Daunoravičius D; Čelutkienė J; Ručinskas K; Grabauskienė V
Cardiol J; 2022; 29(3):441-453. PubMed ID: 32567670
[TBL] [Abstract][Full Text] [Related]
8. Impact of Ischaemic and Dilated Cardiomyopathy on Short-Term and Long-Term Survival After Ventricular Assist Device Implantation: A Single-Centre Experience.
Ivanov B; Djordjevic I; Sabashnikov A; Sindhu D; Hink S; Eghbalzadeh K; Gerfer S; Gaisendrees C; Schlachtenberger G; Rustenbach C; Seuthe K; Regnier K; Mader N; Pfister R; Zeriouh M; Rahmanian P; Wahlers T
Heart Lung Circ; 2022 Mar; 31(3):383-389. PubMed ID: 34598889
[TBL] [Abstract][Full Text] [Related]
9. [Multislice spiral computed tomography of the heart in dilated cardiomyopathy: possibilities in the verification of myocarditis (in comparison with myocardial biopsy) and in the evaluation of prognosis].
Alieva IN; Blagova OV; Gagarina NV; Nedostup AV; Kogan EA; Sedov VP; Kadochnikova VV; Donnikov AE; Zaidenov VA; Kupriyanova AG; Ternovoy SK
Ter Arkh; 2017; 89(12):15-27. PubMed ID: 29411756
[TBL] [Abstract][Full Text] [Related]
10. T1 Mapping and Extracellular Volume Fraction in Dilated Cardiomyopathy: A Prognosis Study.
Li S; Zhou D; Sirajuddin A; He J; Xu J; Zhuang B; Huang J; Yin G; Fan X; Wu W; Sun X; Zhao S; Arai AE; Lu M
JACC Cardiovasc Imaging; 2022 Apr; 15(4):578-590. PubMed ID: 34538631
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy.
Fan KL; Zhang HF; Shen J; Zhang Q; Li XL
Indian Heart J; 2013; 65(1):12-6. PubMed ID: 23438607
[TBL] [Abstract][Full Text] [Related]
12. Plasma osteopontin levels, but not its myocardial expression, reflect heart failure severity in recently diagnosed dilated cardiomyopathy.
Podzimkova J; Palecek T; Kuchynka P; Marek J; Danek BA; Jachymova M; Safarikova M; Kalousova M; Zima T; Linhart A
Herz; 2020 Dec; 45(Suppl 1):105-110. PubMed ID: 31289910
[TBL] [Abstract][Full Text] [Related]
13. The combination of carboxy-terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy - A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy.
Raafs AG; Verdonschot JAJ; Henkens MTHM; Adriaans BP; Wang P; Derks K; Abdul Hamid MA; Knackstedt C; van Empel VPM; Díez J; Brunner-La Rocca HP; Brunner HG; González A; Bekkers SCAM; Heymans SRB; Hazebroek MR
Eur J Heart Fail; 2021 Jun; 23(6):933-944. PubMed ID: 33928704
[TBL] [Abstract][Full Text] [Related]
14. Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients.
Hu DJ; Xu J; Du W; Zhang JX; Zhong M; Zhou YN
Int J Cardiovasc Imaging; 2016 Dec; 32(12):1725-1733. PubMed ID: 27566192
[TBL] [Abstract][Full Text] [Related]
15. Right ventricular morphology and function is not related with microRNAs and fibrosis markers in dilated cardiomyopathy.
Rubiś P; Totoń-Żurańska J; Wiśniowska-Śmiałek S; Kołton-Wróż M; Wołkow P; Wypasek E; Rudnicka-Sosin L; Pawlak A; Kozanecki K; Tomkiewicz-Pająk L; Podolec P
Cardiol J; 2018; 25(6):722-731. PubMed ID: 28840590
[TBL] [Abstract][Full Text] [Related]
16. Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy.
Merlo M; Cannatà A; Pio Loco C; Stolfo D; Barbati G; Artico J; Gentile P; De Paris V; Ramani F; Zecchin M; Gigli M; Pinamonti B; Korcova R; Di Lenarda A; Giacca M; Mestroni L; Camici PG; Sinagra G
Eur J Heart Fail; 2020 Jul; 22(7):1111-1121. PubMed ID: 32452075
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast Growth Factor 21 Correlates with the Prognosis of Dilated Cardiomyopathy.
Gu L; Jiang W; Zheng R; Yao Y; Ma G
Cardiology; 2021; 146(1):27-33. PubMed ID: 33264784
[TBL] [Abstract][Full Text] [Related]
18. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.
aus dem Siepen F; Buss SJ; Messroghli D; Andre F; Lossnitzer D; Seitz S; Keller M; Schnabel PA; Giannitsis E; Korosoglou G; Katus HA; Steen H
Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):210-6. PubMed ID: 25246502
[TBL] [Abstract][Full Text] [Related]
19. Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils.
Taipale J; Saharinen J; Hedman K; Keski-Oja J
J Histochem Cytochem; 1996 Aug; 44(8):875-89. PubMed ID: 8756760
[TBL] [Abstract][Full Text] [Related]
20. Clinical characterization and natural history of chemotherapy-induced dilated cardiomyopathy.
Lalario A; Del Mestre E; Lo Casto M; Nuzzi V; Manca P; Bromage DI; Barbati G; Merlo M; Sinagra G; Cannatà A
ESC Heart Fail; 2022 Oct; 9(5):3052-3059. PubMed ID: 35735911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
